Many women notice changes in their vagina and genital area after the menopause. These changes may include dryness and discomfort during sex. There may also be bladder symptoms. These can all usually be improved with treatment. Treatment options include hormone replacement therapy (HRT), oestrogen cream or pessaries and lubricating gels.
What is atrophic vaginitis and what causes it?
Before the menopause (often called the change of life) the skin and tissues around your vagina are kept supple and moist by fluids and mucus. These are made by glands at the neck of your womb. Oestrogen (the female hormone) affects these glands. Oestrogen also affects your tissues in and around your vagina, causing the lining of your vagina to be thicker and more elastic. Oestrogen also stimulates the cells that line your vagina to produce glycogen, a compound which encourages the presence of helpful germs (bacteria) which protect your vagina from infections.
After the menopause your ovaries make less oestrogen. The lack of oestrogen leads to thinning of the tissues around your vagina and a reduction in the number of glands that make mucus. You may also lose some fat tissue from around the genital area. This may make the area also look slightly different to how it was before the menopause.
In summary, the hormonal changes that occur during the menopause make your vagina shorter, less elastic and drier. These changes usually take months or years to develop after the menopause and vary from woman to woman. Atrophic vaginitis is the medical term for the condition when these changes produce troublesome symptoms.
How common is atrophic vaginitis?
After the menopause about half of women have some symptoms related to atrophic vaginitis. You are also more likely to experience symptoms as more years pass after your menopause. It is probably even more common than that, as many women are embarrassed and feel they do not want to trouble their doctor with these symptoms.
What symptoms can occur?
The changes described above can occur without causing any symptoms or discomfort. However, some of the following symptoms may develop in some women. Atrophic vaginitis is a common (and usually treatable) cause of the following problems. However, these problems can also be caused by other medical conditions.
- Pain when you have sex. This may occur because your vagina is smaller, drier and less likely to become lubricated during sex compared with how it was before the menopause. Also, the skin around your vagina is more fragile, and this can make the problem worse.
- Discomfort - if your vulva or vagina is sore and red.
- Vaginal discharge. There may be a white or yellow discharge. Sometimes this is due to an infection. Infection is more likely if the discharge is smelly and unpleasant.
- Itch. The skin around your vagina is more sensitive and more likely to itch. This can make you prone to scratching, which then makes your skin more likely to itch, and so on. This is called an itch/scratch cycle which can become difficult to break, and can be distressing.
- Urinary problems. Atrophic vaginitis may contribute to various urinary problems. This is because of thinning and weakening of the tissues around the neck of the bladder, or around the opening for urine to pass (the urethra). For example, urinary symptoms that may occur include an urgency to get to the toilet, and recurring urinary infections.
What are the treatments for atrophic vaginitis?
Not all women have all of the above symptoms. Treatment may depend on which symptoms are the most troublesome. Because the problem is mainly due to a lack of oestrogen, it can often be helped by replacing the oestrogen in your tissues.
Hormone replacement therapy (HRT)
This means taking oestrogen in the form of a tablet, gel or patches. This is often the best treatment for relieving your symptoms, but some women don't like the idea of taking HRT. There are advantages and disadvantages of using HRT. See separate leaflet called Menopause and HRT for more detail.
Oestrogen creams and other topical preparations
Sometimes a cream, pessary or vaginal tablet or ring containing oestrogen is prescribed. A pessary is a small soluble block that is inserted into your vagina. The tablet is a very small tablet that you insert into your vagina with a small applicator. The ring is a soft, flexible ring with a centre that contains the oestrogen hormone. This ring releases a steady, low dose of estrogen each day and it lasts for three months.
These preparations work to restore oestrogen to your vagina and surrounding tissues without giving oestrogen to the whole body. Usually the treatment is used every day for about two weeks, and then twice a week for a further three months. After this the effect of the treatment is usually assessed by your doctor. This treatment usually works well but the symptoms may recur some time after stopping the treatment. Repeated courses of treatment are often necessary. These preparations should not be used as additional lubrication during sex; lubricating gels should be used instead.
Note: the oestrogen creams and pessaries may damage latex condoms and diapragms; if you are using these types of contraception then it would be preferable either to use vaginal tablets or the vaginal ring.
If vaginal dryness is the only problem, or hormone creams are not recommended because of other medical problems, lubricating gels may help. There are two gels which are available in the UK that are specifically designed to help the problem of vaginal dryness. They replace moisture. They are Replens® and Sylk®. You can buy these from the pharmacy and your pharmacist should be able to advise you.
Note: Vaseline® can break down the latex in condoms, so is not recommended for women whose partners are using condoms.
Your symptoms should improve after about three weeks of treatment. You should see your doctor if your symptoms do not improve, as sometimes these symptoms can be due to other conditions. It is also very important to see your doctor if you have any bleeding from your vagina if you are receiving hormone treatment.
Further help & information
Further reading & references
- Sturdee DW, Panay N; Recommendations for the management of postmenopausal vaginal atrophy. Climacteric. 2010 Dec;13(6):509-22. doi: 10.3109/13697137.2010.522875. Epub 2010 Sep 30.
- Woods NF; An overview of chronic vaginal atrophy and options for symptom management. Nurs Womens Health. 2012 Dec;16(6):482-93; quiz 494. doi: 10.1111/j.1751-486X.2012.01776.x.
|Original Author: Dr Tim Kenny||Current Version: Dr Louise Newson||Peer Reviewer: Prof Cathy Jackson|
|Last Checked: 13/05/2013||Document ID: 4199 Version: 41||© EMIS|
Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.